Kuros Biosciences Ltd (XSWX:KURN)

Half Year 2025 Kuros Biosciences AG Earnings Call Transcript

Aug 14, 2025 / 01:00 PM GMT

Release Date Price: CHF27.46 (+3.31%)

Transcript

Key Points

Positve

Kuros Biosciences Ltd (CSBTF) reported its first operating profit of $3.5 million, showcasing strong financial performance.
The company achieved a significant revenue growth of 78% in the first half of 2025, reaching over $63.5 million.
Kuros Biosciences Ltd (CSBTF) successfully launched its minimally invasive surgery (MIS) product, which is expected to drive future growth.
The company is expanding its global footprint, with plans to enter new markets such as Canada, Singapore, Japan, and Latin America.
Kuros Biosciences Ltd (CSBTF) maintains a strong cash position, allowing it to fund organic growth and invest in new production facilities without external financing.

Negative

The company anticipates a potential slowdown in growth in the second half of the year, despite strong first-half performance.
Tariffs remain a concern, although the company has taken measures to mitigate their impact, such as stockpiling in the US.
There is uncertainty regarding the full impact of tariffs in the future, with potential costs estimated in the lower single-digit millions.
The company faces challenges in maintaining and improving margins due to ongoing investments in growth and transformation initiatives.
Kuros Biosciences Ltd (CSBTF) has not provided specific timelines for future product launches, creating uncertainty about the pipeline's impact on growth.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KURN.S - Kuros Biosciences AG
Half Year 2025 Kuros Biosciences AG Earnings Call
Aug 14, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Yeah, good afternoon, ladies and gentlemen. I welcome you to our presentation of Cos He year Results 2025. My name is Alex Mueller, and responsible for invest relations, and I'm joined by Chris Fair, our CEO, and Daniel Geiger, our CFO, who will present the Havier results. The presentation will be followed by a Q&A session, and you can submit your questions either over the phone or via the webcast tool.

I would like to remind you that the slides from today's presentation as well as the press release and the half year report are all available on our website.

And with that, I would like to hand over to Chris to start with the presentation.

------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.